Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene delivery therapy, immunotherapy, and vaccinology.

Channel 4 is planning to take majority stakes in third-party production companies as part of its plan to move into in-house ...

Channel 4 published its annual report against the backdrop of executive upheaval, with CEO Alex Mahon following chair Ian ...